SterileAtlasIntelligence Mission Control
Sign in
Ethics review
Ethics ReviewCompare

Compare · Ethics Review

3/4 organizations · live data

Side-by-side matrix of up to 4 real IRBs / ethics committees — the six deterministic scoring engines, review-timeline & capacity metrics and the accreditation, service, study-type, review-service, therapeutic-area, language & country matrices, with the best value in each numeric row highlighted.

Scores deterministic, rules-based — not AI. Organization names are real; accreditation status, timelines, metrics & satisfaction scores are synthetic — verify against official AAHRPP/OHRP/FWA registries. Not an ethics-review determination.

US · UK · Japan mixUS central IRBsWCG vs AdvarraUK · Canada · Australia
Select organizations to compare (3/4)
3 organizations
59oversight
Toronto, ON · Canada
68oversight
Adelaide, SA · Australia
Overview & timelines
HRA/NRESCTOBellberry
TypeNational Ethics BoardRegional Ethics CommitteeIndependent IRB
RegionEuropeNorth AmericaOceania
HeadquartersLondon, United KingdomToronto, ON, CanadaAdelaide, SA, Australia
Founded201120122004
Reviewers
Avg full-board approval (days)
Avg expedited review (days)
Avg amendment (days)
Annual protocol volume
Active studies
Cost modelCustom quoteCustom quotePer-protocol
Satisfaction (illustrative)
Verified
Ethics-review scorecard · deterministic 0–100
HRA/NRESCTOBellberry
Oversight strength How broad the organization's human-subject-protection mandate is — combining its accreditation footprint, the range of review services it offers and the breadth of study types it reviews.
61
59
68
Accreditation strength How strong the organization's credentials are, weighted by the rigor each signals — AAHRPP counts heaviest, then OHRP and FDA registration, ICH E6(R3), Declaration of Helsinki and GCP alignment.
30
30
65
Review velocity How quickly the organization turns reviews around, driven mainly by its average full-board approval time with a bonus for fast expedited reviews.
0
0
0
Geographic reach How widely the organization can review across geographies — from the countries and regions it serves, central-IRB availability and the number of languages supported.
28
31
28
Therapeutic depth How deep the organization's clinical expertise runs — from the number of therapeutic areas covered plus pediatric, cell-and-gene, device and decentralized-trial experience.
90
53
53
Capacity & scale The organization's review throughput and capacity — from annual protocol volume, active study count, reviewer headcount and full-board meeting frequency.
0
0
0

Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.

Accreditation & compliance
HRA/NRESCTOBellberry
AAHRPP
ICH E6(R3) aligned
Declaration of Helsinki
GCP compliant
Service capabilities
HRA/NRESCTOBellberry
Single IRB
Central IRB
Commercial reviews
Academic reviews
Pediatric experience
Cell & gene therapy
Device trials
Decentralized trials
eConsent
Study types reviewed
HRA/NRESCTOBellberry
Phase I
Phase II
Phase III
Phase IV
Medical devices
Biologics
Vaccines
Rare disease
Pediatric
Oncology
Observational
Decentralized trials
Review services
HRA/NRESCTOBellberry
Protocol review
Informed consent review
Recruitment material review
Amendment review
Continuing review
Safety report review
Full board review
Central IRB
Therapeutic-area experience
HRA/NRESCTOBellberry
Oncology
Neurology
Rare diseases
Infectious diseases
Cardiovascular
Endocrinology
Dermatology
Immunology
Cell & gene therapy
Pediatrics
Vaccines
Languages
HRA/NRESCTOBellberry
English
French
Geographic coverage (countries)
HRA/NRESCTOBellberry
Australia
Canada
United Kingdom

Synthetic capability & accreditation flags · not an ethics-review or vendor-qualification determination — verify accreditation directly against official AAHRPP/OHRP/FWA registries before any sIRB / oversight decision.

ComparingHRA/NRESCTOBellberryAAHRPPICH E6(R3)
Best in row · deterministic, rules-based — not AI · illustrative seed data